A Unique Environment in the Heart of Paris

Situated on the iconic Pierre et Marie Curie Campus of Sorbonne Université, this position offers an exceptional intellectual home for researchers who want to blend rigorous biological inquiry with transformative technology. Three complementary structures form the backbone of this opportunity.

The ELiS Lab has a long track record of nurturing young group leaders and championing high-risk, interdisciplinary science. Current activities span synthetic organelles for sustainable bioproduction, AI-guided antimicrobial peptide discovery, natural product and drug discovery from soil bacteria, bacterial consortia, synthetic phages, and synthetic cells. The lab has been engaged in teaching through research via iGEM since 2006 and maintains a strong commitment to open, citizen science.

The Paris Biofoundry, part of the Sorbonne University Alliance, specialises in fully automated, high-throughput DNA assembly and microorganism engineering — with a focus on bacteria, yeast and microalgae — as well as large-scale automated phenotyping.

The Computational, Quantitative & Synthetic Biology Department brings together 15 teams spanning experimental, computational and theoretical life sciences. Research strengths include AI, statistical modelling, genome evolution, synthetic gene circuits and metabolic networks — an ideal substrate for interdisciplinary discovery.

“We hope to attract a scientist who wants to shape the future in a collaborative, international and intellectually open environment.”
— Ariel Lindner, Director of Research, INSERM

What the Position Offers

The Inserm CPJ (Chaire de Professeur Junior) is a prestigious four-year tenure-track appointment, with the prospect of becoming an Inserm Research Director upon successful evaluation. The package is designed to give a new group leader everything they need to start boldly.

Starting Package

€200,000

Research startup funding

• Full salary from day one
• Autonomy to create and lead an independent group
• Access to ANR, ERC, HFSP, EMBO and all national/international funding
• Immersion in a supportive, mentoring environment
• Full access to Paris Biofoundry automation ecosystem

Position type : 4-Year Tenure-Track

Location : Pierre et Marie Curie Campus, Paris

Starting package : €200,000

Application deadline : 2 September 2026

Who Should Apply?

The search is open to creative, independent scientists with a strong vision and the drive to build something genuinely new. Relevant backgrounds include — but are not limited to:

• Synthetic biology & systems biology
• Computational biology & biophysics
• AI/ML applied to biological discovery
• Microbial engineering & phage biology
• Biofoundry automation & high-throughput design
• Drug discovery, protein engineering & metabolic engineering

Above all, the lab is looking for someone excited by connecting computation and experimentation, engineering and evolution, and fundamental biology with health innovation.

How the Recruitment Works

Informal conversations and lab visits are actively encouraged through the end of July 2026. Prospective candidates are warmly invited to reach out early — both to explore scientific fit and to develop their project ideas before the formal deadline.

The formal submission deadline is 2 September 2026.

L’article Join the ELiS Lab: Synthetic Biology, AI & Health est apparu en premier sur Paris Biofoundry.

The Paris Biofoundry is pleased to announce that it will host the Global Biofoundry Alliance (GBA) Summit 2026, which will take place from November 16 to 18, 2026 at the Cité de l’Innovation on the Sorbonne Université campus in Paris.

The GBA Summit is the flagship annual event of the international biofoundry community. It brings together leading academic and industrial biofoundries, researchers, engineers, industry representatives, and policymakers to exchange on the latest advances in automated biology, high-throughput engineering, and synthetic biology infrastructures. Over the years, the summit has become a key forum to foster collaboration, share best practices, and coordinate efforts toward more interoperable and scalable biofoundry ecosystems worldwide.

The 2026 edition will continue this tradition, offering a program of scientific presentations, technology showcases, and strategic discussions. Topics will include the development of Design–Build–Test–Learn (DBTL) workflows, integration of automation and artificial intelligence, advances in bioproduction and scale-up, as well as challenges related to standardization, data management, and biosecurity.

Hosting the GBA Summit in Paris reflects the growing role of the Paris Biofoundry within the global biofoundry network. As the first academic biofoundry in France, the Paris Biofoundry brings together leading institutions across the Île-de-France region in a distributed infrastructure dedicated to accelerating synthetic biology research and innovation.

Following previous editions hosted in different parts of the world, including Asia and North America, the 2026 summit will further strengthen international collaboration and reinforce the role of biofoundries as key infrastructures for addressing global challenges in health, environment, and sustainable industry.

The Paris Biofoundry looks forward to welcoming the global biofoundry community to Paris for this major event.

Register now through the event website by clicking here.

L’article The Paris Biofoundry is hosting the Global Biofoundry Alliance Summit 2026 est apparu en premier sur Paris Biofoundry.

This session provided prospective applicants with a comprehensive overview of the call, including its funding framework, thematic scope, eligibility criteria, evaluation process, and key dates. The webinar also presented the technological capabilities of the Paris Biofoundry and clarified how selected projects will benefit from automated Design–Build–Test–Learn (DBTL) workflows and the support of dedicated research engineers.

For those who were unable to attend — or who wish to revisit the presentation — the full webinar recording is now available online:

Access the webinar replay by clicking here.

We encourage prospective applicants to watch the replay and to contact the Paris Biofoundry team in advance of submission to discuss project feasibility and alignment with our technological infrastructure.

For further inquiries: sciences-biofonderie-direction@sorbonne-universite.fr

L’article Replay Available – Paris Biofoundry 2026 Call for Proposals Zoom Webinar est apparu en premier sur Paris Biofoundry.

The Paris Biofoundry is pleased to announce that the Global Biofoundry Alliance (GBA) 2026 Conference will take place from November 16 to 18, 2026, at Sorbonne Université in Paris, France.

Organized by the Paris Biofoundry, this major international event will bring together members of the Global Biofoundry Alliance, as well as leading scientists, engineers, industry representatives, policymakers, and innovators from across the synthetic biology and bioengineering communities.

The Global Biofoundry Alliance is an international network of non-commercial biofoundries dedicated to advancing automated, high-throughput biology and fostering collaboration, standardization, and open innovation in synthetic biology. The annual GBA conference serves as a key forum for sharing technological advances, discussing strategic challenges, and strengthening global partnerships across academia, industry, and public institutions.

Hosting the 2026 edition at Sorbonne Université underscores the growing role of the Paris Biofoundry within the international biofoundry ecosystem and highlights France’s commitment to advancing cutting-edge bioengineering infrastructures under initiatives such as France 2030.

Over three days, the conference will feature scientific presentations, technology showcases, roundtable discussions, and networking sessions addressing topics such as automated Design–Build–Test–Learn workflows, AI-driven bioengineering, standards and interoperability, scale-up and industrial translation, and the evolving role of biofoundries in supporting innovation ecosystems.

Further details regarding the scientific program, keynote speakers, registration, and sponsorship opportunities will be announced in the coming months.

The Paris Biofoundry looks forward to welcoming the global biofoundry community to Paris in November 2026 for what promises to be a landmark event in the field of automated synthetic biology.

L’article The Global Biofoundry Alliance (GBA) 2026 summit will be hosted by the Paris Biofoundry ! est apparu en premier sur Paris Biofoundry.

L’article Join the Biofoundry Open Opportunity for SynBio Tech (BOOST) information meeting ! est apparu en premier sur Paris Biofoundry.

This visit provided an opportunity to present the structure, technological capabilities, and distributed model of the Paris Biofoundry, including its automated Design–Build–Test–Learn (DBTL) workflows and high-throughput engineering platforms. Our Japanese colleagues introduced their recent scientific advances, ongoing research programs, and long-term strategy for strengthening Japan’s biofoundry ecosystem.

The discussions focused on automation strategies, standardization approaches, and the role of biofoundries in accelerating synthetic biology at national and international scales. Particular attention was given to identifying complementary expertise and exploring future avenues for collaboration, including joint projects, technology exchanges, and strengthened international networking.

Such exchanges reinforce the importance of global cooperation in building interoperable biofoundries capable of addressing major societal challenges in health, environment, and industry.

The Paris Biofoundry looks forward to continued dialogue and future collaborations with its Japanese partners.

L’article The Paris Biofoundry Welcomes a Japanese Delegation from Kobe Biofoundry est apparu en premier sur Paris Biofoundry.

During the meeting, both teams presented their respective infrastructures, automation pipelines, and strategic priorities in synthetic biology. The Paris Biofoundry introduced its distributed academic model, high-throughput DNA assembly, microbial and cell-free engineering capabilities, and scale-up facilities.

Our Korean counterparts shared their recent breakthroughs and national initiatives aimed at reinforcing South Korea’s leadership in biofoundry development.

The discussions focused on potential collaborative initiatives, including knowledge exchange, workflow interoperability, and opportunities for joint research and innovation projects.

This meeting reflects the growing importance of international partnerships in advancing automated biological engineering and fostering a globally connected biofoundry community.

L’article Strengthening Ties with the Korean Biofoundry Ecosystem est apparu en premier sur Paris Biofoundry.

DNA part synthesis & high-throughput plasmid assembly
(96-well plate MoClo-based automated workflows)

In-vivo engineering – genetic modifications, genotyping, and phenotyping
(FACS, microscopy, fluorescence, proteomics, metabolomics)
Using the chassis operated at the Paris Biofoundry (Bacteria, yeasts, algae, mammalian cells)

Cell-free engineering – screening, bioproduction, biosensing
(Based on cell extracts or PURE systems)

Bioprocess scale-up – biological production from liter-scale to multi-liter reactors

Project leaders do not receive direct financial transfers, but benefit from: 50% coverage of experimental costs, up to €100,000 total budget (50% Paris Biofoundry + 50% co-funding required from the applicant) and an access to a dedicated engineer performing experiments on-site using Paris Biofoundry automated workflows.

This call aims to select scientific projects that will help validate, improve, and expand our automated DBTL pipelines and services for the broader academic, industrial, and startup community.

Projects must be located within the Île-de-France region to be eligible for the call.

Timeline

• December 1, 2025 – Launch of the Call for Projects
• Dec 1, 2025 → March 30, 2026 – Technical dialogue with the Paris Biofoundry to evaluate feasibility & cost structure
• March 30, 2026 – Submission deadline
• April 2026 – Project pre-selection
• April 2026 – External expert evaluations
• April 2026 – Final selection jury
• April 30, 2026 – Announcement of selected projects
• June 2026 → June 2027 – Project execution period

For more details please consult the call of proposal document bellow.

Appel à projets scientifiques – Sésame Filières Biofonderie de Paris

Questions & expressions of interest are to be sent to the following email address : sciences-biofonderie-direction@sorbonne-universite.fr

L’article The Paris Biofoundry launches a Call for proposals est apparu en premier sur Paris Biofoundry.

The Paris Biofoundry is pleased to have participated in Forum Biotechno Paris 2025, a key event dedicated to the future of biotechnology and scientific careers.

As part of the Flash Talk session, Victor Kreis, President of Reseau BioTechno, introduced the Paris Biofoundry and its mission to accelerate biotechnological innovation through a unique alliance of leading Parisian institutions. The presentation highlighted how the Biofoundry model integrates automation, synthetic biology, and data-driven design to support projects from conceptualization to practical application.

Forum Biotechno provided an excellent opportunity to engage with students, early-career scientists, researchers, and innovation stakeholders interested in emerging biotechnological infrastructures and career pathways. The Paris Biofoundry team was delighted to exchange with participants and to present how automated Design–Build–Test–Learn workflows are transforming research practices and bioengineering development.

We warmly thank the organizers of Forum Biotechno Paris for fostering meaningful dialogue between academia and industry and for providing a dynamic platform to showcase the future of biotechnology.

L’article The Paris Biofoundry at the Forum Biotechno Paris 2025 est apparu en premier sur Paris Biofoundry.

The Paris Biofoundry is pleased to participate in DIM BioConvS Innovation Day 2025, a flagship event dedicated to fostering collaboration across synthetic biology, biotherapies, and technological innovation within the Île-de-France research ecosystem.

This year’s symposium brings together scientists, startups, research platforms, and institutional partners from across the DIM BioConvS network to highlight interdisciplinary advances and strengthen strategic synergies between fundamental research and applied innovation.

During the opening session, Ariel Lindner, Chief Scientific Officer of the Paris Biofoundry, delivered a keynote presentation addressing key issues at the intersection of bioethics, biocontainment, and bioengineering in the era of synthetic biology. His talk emphasized the importance of responsible innovation and regulatory foresight as automated bioengineering technologies continue to expand.

In addition, Ramiz Khaled and Mostafa Mahdy Khalil (Institut Micalis – INRAE, Université Paris-Saclay) presented “Automated Workflows to Operate the Paris Biofoundry,” showcasing recent advances in laboratory automation, standardized Design–Build–Test–Learn workflows, and data-driven research strategies supporting high-throughput synthetic biology.

The Paris Biofoundry is also participating in the “Stands Village,” where scientific infrastructures and technological platforms present their services and tools. This space provides an excellent opportunity to engage with the broader community, exchange expertise, and explore new collaborative opportunities across disciplines.

We are proud to contribute to this collective effort to strengthen innovation in synthetic biology and biotherapies within the DIM BioConvS framework.

L’article The Paris Biofoundry at DIM BioConvS Innovation Day 2025 est apparu en premier sur Paris Biofoundry.